Moderna has started dosing participants in a study examining its COVID-19 vaccine candidate in adolescents.
The company announced Thursday the beginning of this trial that will enroll 3,000 U.S. participants to study the safety and efficacy of the coronavirus vaccine in adolescents aged 12 to less than 18, Reuters reports.
"Our goal is to generate data in the spring of 2021 that will support the use of mRNA-1273 in adolescents in advance of the 2021 school year," Moderna CEO Stéphane Bancel said.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Moderna previously announced that a late-stage trial showed its COVID-19 vaccine candidate is almost 95 percent effective in adults, and the company has applied for an emergency use authorization from the Food and Drug Administration. It's one of two companies that applied for FDA authorization for a COVID-19 vaccine, the other being Pfizer.
Bancel also said Thursday that this "adolescent study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population," adding, "we hope we will be able to provide a safe vaccine to provide protection to adolescents so they can return to school in a normal setting."
-
Eel-egal trade: the world’s most lucrative wildlife crime?Under the Radar Trafficking of juvenile ‘glass’ eels from Europe to Asia generates up to €3bn a year but the species is on the brink of extinction
-
Political cartoons for November 2Cartoons Sunday's political cartoons include the 22nd amendment, homeless camps, and more
-
The dazzling coral gardens of Raja AmpatThe Week Recommends Region of Indonesia is home to perhaps the planet’s most photogenic archipelago.
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
